Navigation Links
Clinilabs Opens Phase I Unit In Eatontown, New Jersey
Date:5/28/2012

NEW YORK, May 28, 2012 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I unit in Southern New Jersey.  The 50-bed capacity, 15,000 square foot Specialty Pharma Phase I Unit features semi private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy, and exam rooms.

Since 2001, Clinilabs has successfully completed clinical trials involving healthy, adult human volunteers and specialty patient populations.  The staff has accrued experience in over 800 clinical studies, offering clients the service capacity of a big CRO – delivered by an organization that is right-sized and priced for early phase projects.  The opening of the New Jersey Specialty Pharma Phase I Unit expands services currently offered at the company's 50 bed, state-of-the-art, Phase I unit in Manhattan, raising total bed capacity to 100.

"I am pleased to announce the opening of our new unit in Eatontown, New Jersey", states Dr. Gary Zammit.  "This unit allows us to expand our Phase I capacity in two locations, providing first-in-human through end-of-phase II CRO services to our clients.  We are now able to enroll larger samples of normal healthy volunteers and patient populations at our two units and at investigator sites worldwide."

About Clinilabs Inc.

Clinilabs is a contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. We offer teams, processes, and technology solutions that are designed to serve single center and multicenter early-phase studies – services that can be scaled as needed to meet the requirements of any clinical development program. For more information, please visit www.clinilabs.com.

Media Contact: Hannah DAoust Clinilabs, 646-215-6480, hdaoust@clinilabs.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Clinilabs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
4. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
5. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
8. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
9. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
10. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
11. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... COPENHAGEN, Denmark , March 23, 2017 ... utilizes its innovative TransCon technology to address significant unmet ... company will host a conference call and webcast on ... of the Endocrine Society in Orlando, Florida ... rare disease pipeline candidates (TransCon Growth Hormone, TransCon PTH ...
(Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
(Date:3/23/2017)... 2017 Piramal Pharma Solutions ... el nombramiento de Stuart E. Needleman ... servicios integrados completa para su base de clientes ... en el crecimiento y ejecución de las ofertas ... impulsar todas las actividades de desarrollo empresarial global ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... , ... March 23, 2017 - Crawford Technologies announced today ... invoices, bills, statements and other correspondence when they have been lost or destroyed. ... print the documents and batch them for efficient handling. , Many organizations ...
(Date:3/23/2017)... ... March 23, 2017 , ... Sharon Kleyne, host of the ... and Your Health on VoiceAmerica, recently talked on her program about how she is ... occasion to remind listeners of an important distinction. World Water Day, Kleyne pointed out, ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: a call to heal the wounded ... published author, Desiree M Webb, a registered nurse, minister of music, speaker, songwriter, recording ... her husband, Paul, for over twenty-nine years. Desiree enjoys writing, beach trips, ministering ...
Breaking Medicine News(10 mins):